BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16449669)

  • 1. Methylation of Stat1 promoter can contribute to squamous cell carcinogenesis.
    Lee H; Yu H
    J Natl Cancer Inst; 2006 Feb; 98(3):154-5. PubMed ID: 16449669
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Wong TS; Liu XB; Ng RW; Wei WI; Yuen AP
    J Natl Cancer Inst; 2007 Sep; 99(17):1343-4; author reply 1344. PubMed ID: 17728220
    [No Abstract]   [Full Text] [Related]  

  • 4. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1.
    Lui VW; Boehm AL; Koppikar P; Leeman RJ; Johnson D; Ogagan M; Childs E; Freilino M; Grandis JR
    Mol Pharmacol; 2007 May; 71(5):1435-43. PubMed ID: 17325127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
    Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LHX6 is a sensitive methylation marker in head and neck carcinomas.
    Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
    Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 14. [The relationship between methylation of p16 INK 4/CDKN2 gene in promoter region and progress of squamous cell carcinoma of buccal mucosa].
    Dong YY; Wang J; Dong FS; Wang X; Li HX; Gu HT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):297-8. PubMed ID: 16784614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-8 levels correlate with the expression of signal transducer and activator of transcription 1 in high-grade but not lower grade neuroblastoma.
    Muscat A; Hawkins C; Ashley DM
    Cancer; 2006 Aug; 107(4):824-31. PubMed ID: 16886176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo.
    Kaganoi J; Watanabe G; Okabe M; Nagatani S; Kawabe A; Shimada Y; Imamura M; Sakai Y
    Ann Surg Oncol; 2007 Apr; 14(4):1405-15. PubMed ID: 17195908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.